Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions GlobeNewswire November 24, 2025 Oral macrocyclic peptides have the potential to offer biologic-like efficacy and safety in a convenient oral format Collaboration further advances Biogen's immunology strategy by broadening its early-stage pipeline and incorporating an […]

Dragonfly Energy to Supply Werner Enterprises with Advanced Idle-Reduction Power Systems GlobeNewswire November 24, 2025 Werner Enterprises, Inc. (Nasdaq: WERN) has placed their first order for Battle Born(R) DualFlow Power Pack systems following an extensive long-term pilot with Dragonfly Energy. The lithium-powered, American-assembled systems provide reliable hotel load power during rest periods: reducing idling, fuel

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your CarMax, Inc. (NYSE:KMX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/carmax-inc-lawsuit-submission-form?prid=178860&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=178859&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

(NasdaqGM:VERA), BRISBANE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company's management team will present and participate in one-on-one meetings at upcoming investor conferences. Investor Conference Details: 8th Annual

Canned Tuna Market Size, Trends, Key Manufacturers, and Import/Export Data to 2034 According to Towards FnB, the global canned tuna market size is evaluated at USD 34.56 billion in 2025 and is expected to hit USD 45.49 billion by 2034, reflecting at a CAGR of 3.1% from 2025 to 2034. This growth underscores the rising

Vera Therapeutics to Participate at Upcoming Investor Conferences GlobeNewswire November 24, 2025 BRISBANE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company's management team will present and participate in

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Freeport-McMoRan Inc. (NYSE:FCX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/freeport-mcmoran-inc-lawsuit-submission-form?prid=178857&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in aTyr between January 16, 2025 and September 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Synopsys, Inc. (NASDAQ:SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=178855&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call